Westlake Village-based Energy Vault will go public after entering into an agreement with the special purpose acquisition company Norvus Capital Corp., in a deal worth up to $388 million. The combined company will have an enterprise value of about $1.1 billion once the deal is complete, according to a Sept. 9 news release from Energy Read More →
Shares of Camarillo-based Semtech climbed nearly 10% after a strong earnings report on Sept. 1, and in the following week continued to trade at their highest levels since February. Semtech, a semiconductor company specializing in Internet of Things applications, closed at $77.50 on Sept. 7. That was 9% above its closing price of $71.13 on Read More →
Olaplex, a hair care products company founded in Santa Barbara using technology developed by UCSB chemists, is planning an initial public stock offering. The company filed a prospectus with the U.S. Securities and Exchange Commission on Aug. 27, but the filing gave no details on the price of the shares, the number of shares to Read More →
Semtech Corp., a Camarillo semiconductor company specializing in Internet of Things applications, saw shares up more than 5% after the markets closed Sept. 1 after the company shared a record-breaking financial statement for the second quarter of fiscal year 2021-22. Semtech delivered earnings of $32.2 million, or 50 cents per share, for the second quarter Read More →
QAD, a Santa Barbara-based cloud software company for the manufacturing industry, saw its revenue and expenses rise in the second quarter of 2021 as the company prepares to be bought out by a San Francisco-based private equity firm. QAD lost $6.3 million, or 31 cents per share, in the quarter ended July 31, the company Read More →
Teledyne Technologies Chairman Robert Mehrabian, who spent two decades as the company’s CEO, will step back into that post when Teledyne’s current CEO, Al Pichelli, retires on Oct. 15. Mehrabian is Pichelli’s predecessor as well as his successor — Pichelli took over as CEO on Jan. 1, 2019 when Mehrabian stepped down. Mehrabian was president Read More →
Arcutis Biotherapeutics announced Aug. 25 that it has enrolled the first patient in a Phase 3 clinical trial to evaluate ARQ-154, its topical foam, as a treatment for scalp and body psoriasis. The foam is a once-daily formulation of roflumilast, a phosphodiesterase type 4 inhibitor that the company is developing to treat two skin conditions: Read More →